Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Tarsus Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +13 vs. Q2 2023
- Shares held
- 29.8M
- +8.36M (+39.0%) vs. Q2 2023
- Total value
- $529.4M
- +$142.1M (+36.7%) vs. Q2 2023
- New holders
- 25
- 49 more added
- Sold out
- 12
- 13 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $2.98B |
| Q1 2026 | 253 | $3.17B |
| Q4 2025 | 246 | $3.61B |
| Q3 2025 | 220 | $2.67B |
| Q2 2025 | 205 | $1.87B |
| Q1 2025 | 195 | $2.26B |
| Q4 2024 | 195 | $2.23B |
| Q3 2024 | 162 | $1.43B |
| Q2 2024 | 148 | $1.09B |
| Q1 2024 | 157 | $1.43B |
| Q4 2023 | 116 | $652.0M |
| Q3 2023 | 105 | $529.4M |
| Q2 2023 | 92 | $387.3M |
| Q1 2023 | 74 | $252.1M |
| Q4 2022 | 69 | $301.0M |
| Q3 2022 | 75 | $350.8M |
| Q2 2022 | 73 | $291.7M |
| Q1 2022 | 51 | $222.2M |
| Q4 2021 | 43 | $294.2M |
| Q3 2021 | 44 | $277.4M |
| Q2 2021 | 44 | $378.5M |
| Q1 2021 | 41 | $410.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 2,140,586 | $38.0M | 5.37% | +361,428+20.3% | Added |
| BlackRock Inc. | 2,210,323 | $39.3M | 0.00% | +10,570+0.5% | Added |
| Vivo Capital, LLC | 2,262,200 | $40.2M | 4.97% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 2,621,422 | $46.6M | 2.72% | +1,200,000+84.4% | Added |
| RTW Investments, LP | 2,880,701 | $51.2M | 1.08% | +332,576+13.1% | Added |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −146,194−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −47,152−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −41,769−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −41,667−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −32,435−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −23,451−100.0% | Sold out |
| Innovis Asset Management LLC | 0 | $0 | 0.00% | −13,141−100.0% | Sold out |
| Sargent Investment Group, LLC | 0 | $0 | 0.00% | −10,045−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −9,331−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −5,383−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −1,289−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −572−100.0% | Sold out |